Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377949 · ClinicalTrials.gov registry record
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
A clinical trial, sponsored by Georgetown University.
- Completed
- Registry status
- 602
- Enrollment target
NCT00377949: Completed study, sponsored by Georgetown University.
NCT00377949 is a clinical trial that has completed, run by Georgetown University. The registered enrollment target is 602 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00377949 has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- 602 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the timeline of progression from pre-pulmonary hypertension to diagnosable pulmonary hypertension based on right heart catheterization. Moreover, to determine the timeline for progression from diagnosable pulmonary hypertension to clinical worsening of disease as defined as death, hospitalization, or worsening of PHT symptoms.
Primary Outcome
The primary objective of the study is to determine the timeline of progression from pre-pulmonary hypertension to diagnosable pulmonary hypertension based on right heart catheterization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 602 participants |
| Start Date | 2005-02 |
What the finished NCT00377949 record still lists
NCT00377949 is an observational study that tracks outcomes without assigning an intervention. The registered 602 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00377949 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00377949 about?
NCT00377949 is a clinical study titled "Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients". The purpose of this study is to determine the timeline of progression from pre-pulmonary hypertension to diagnosable pulmonary hypertension based on right heart catheterization. Moreover, to determine the timeline for progression from diagnosable pulmonary hypertension to clinical worsening of disea...
What is the current status of trial NCT00377949?
This trial is currently completed. The enrollment target is 602 participants. The study started on 2005-02.
Who is sponsoring clinical trial NCT00377949?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03849443 · 604 participants · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia